The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 27876250 |
60 |
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH |
Jagiellonian University Medical College |
| 26988801 |
55 |
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents. |
Jagiellonian University Medical College |
| 26819673 |
55 |
Tetrahydroisoquinoline Phenols: Selective Estrogen Receptor Downregulator Antagonists with Oral Bioavailability in Rat. |
Astrazeneca |
| 26390077 |
42 |
Tactical Approaches to Interconverting GPCR Agonists and Antagonists. |
University of Minnesota |
| 26316468 |
53 |
Design, synthesis and biological evaluation of multifunctional ligands targeting opioid and bradykinin 2 receptors. |
University of Arizona |
| 23582449 |
20 |
Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor. |
Institute of Organic Synthesis |
| 23466604 |
36 |
Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds. |
Universit£ |
| 23403082 |
28 |
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells. |
Broad Institute of Mit and Harvard |
| 22369198 |
40 |
From bradykinin B2 receptor antagonists to orally active and selective bradykinin B1 receptor antagonists. |
Laboratoires Fournier |
| 22342268 |
98 |
Design and synthesis of novel sulfonamide-containing bradykinin hB(2) receptor antagonists. Synthesis and structure-relationships ofa,a-tetrahydropyranylglycine. |
Menarini Ricerche |
| 19473027 |
21 |
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists. |
National Institute of Neuroscienc |
| 15027853 |
72 |
A new series of highly potent non-peptide bradykinin B2 receptor antagonists incorporating the 4-heteroarylquinoline framework. Improvement of aqueous solubility and new insights into species difference. |
Fujisawa Pharmaceutical |
| 15139763 |
41 |
Discovery of the first non-peptide full agonists for the human bradykinin B(2) receptor incorporating 4-(2-picolyloxy)quinoline and 1-(2-picolyl)benzimidazole frameworks. |
Fujisawa Pharmaceutical |
| 15115408 |
64 |
A new class of nonpeptide bradykinin B(2) receptor ligand, incorporating a 4-aminoquinoline framework. Identification of a key pharmacophore to determine species difference and agonist/antagonist profile. |
Fujisawa Pharmaceutical |
| 12014954 |
32 |
Nonpeptide bradykinin B2 receptor antagonists: conversion of rodent-selective bradyzide analogues into potent, orally-active human bradykinin B2 receptor antagonists. |
Novartis Institute For Medical Sciences |
| 10514289 |
18 |
Synthesis and characterization of bradykinin B(2) receptor agonists containing constrained dipeptide mimics. |
University of Montpellier |
| 10514288 |
12 |
Design and synthesis of potent bradykinin agonists containing a benzothiazepine moiety. |
University of Montpellier |
| 9804698 |
44 |
A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 4. Discovery of novel frameworks mimicking the active conformation. |
Fujisawa Pharmaceutical |
| 9767643 |
127 |
A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 3. Discovering bioisosteres of the imidazo[1,2-a] pyridine moiety. |
Fujisawa Pharmaceutical |
| 9767642 |
76 |
A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 2. Overcoming the species difference between guinea pig and man. |
Fujisawa Pharmaceutical |
| 8394936 |
11 |
Design of potent non-peptide competitive antagonists of the human bradykinin B2 receptor. |
Sterling Winthrop Pharmaceutical Research Division |
| | 4 |
Ace inhibitors as a template for the design of bradykinin B2 receptor antagonists |
TBA |
| | 3 |
Synthesis of non-peptide bradykinin B2 receptor antagonists |
TBA |
| | 40 |
Structure activity relationships of non-peptide bradykinin B2 receptor antagonists |
TBA |
| 20813948 |
63 |
Spiroindolones, a potent compound class for the treatment of malaria. |
Swiss Tropical and Public Health Institute |
| 20591666 |
66 |
A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase. |
Università |
| 19552431 |
104 |
Novel small molecule bradykinin B2 receptor antagonists. |
Jerini |
| | 4 |
Synthesis and biological activity of new bradykinin pseudopeptide B1 receptor agonists containing alkylic spacers |
TBA |
| 17243660 |
42 |
Identification of a nonpeptidic and conformationally restricted bradykinin B1 receptor antagonist with anti-inflammatory activity. |
Amgen |
| 17228869 |
44 |
Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists. |
Merck Research Laboratories |
| 16480259 |
22 |
Cyclopropylamino acid amide as a pharmacophoric replacement for 2,3-diaminopyridine. Application to the design of novel bradykinin B1 receptor antagonists. |
TBA |
| 15588075 |
33 |
2,3-diaminopyridine bradykinin B1 receptor antagonists. |
Merck Research Laboratories |
| 15546726 |
22 |
Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studies. |
Merck Research Laboratories |
| 15341478 |
13 |
Potent and orally bioavailable non-peptide antagonists at the human bradykinin B(1) receptor based on a 2-alkylamino-5-sulfamoylbenzamide core. |
TBA |
| 12749889 |
2 |
Design and synthesis of novel pyrrolidine-containing bradykinin antagonists. |
Johnson & Johnson Pharmaceutical Research & Development |
| 12657278 |
38 |
Synthesis and structure--activity relationships of aroylpyrrole alkylamide bradykinin (B2) antagonists. |
Johnson & Johnson Pharmaceutical Research and Development |
| 11078192 |
18 |
Structure-based design of six novel classes of nonpeptide antagonists of the bradykinin B2 receptor. |
Roche Bioscience |
| 10882365 |
4 |
A rational approach to the design and synthesis of a new bradykinin B(1) receptor antagonist. |
University of Montpellier |
| 10882364 |
19 |
Synthesis and biological evaluation of bradykinin B(1)/B(2) and selective B(1) receptor antagonists. |
University of Montpellier |
| 10091703 |
8 |
The design of non-peptide human bradykinin B2 receptor antagonists employing the benzodiazepine peptidomimetic scaffold. |
Novartis Institute For Medical Sciences |
| 31376564 |
13 |
Cinnamamide: An insight into the pharmacological advances and structure-activity relationships. |
National Institute of Pharmaceutical Education and Research (NIPER) |
| 8759638 |
6 |
Synthesis and characterization of pseudopeptide bradykinin B2 receptor antagonists containing the 1,3,8-triazaspiro[4.5]decan-4-one ring system. |
Scios Nova |
| 29631962 |
252 |
Identification and biological evaluation of thiazole-based inverse agonists of ROR?t. |
Phenex Pharmaceuticals |
| 26469307 |
7 |
Phosphorylation of Capsaicinoid Derivatives Provides Highly Potent and Selective Inhibitors of the Transcription Factor STAT5b. |
University of Leipzig |
Search and Browse
